mortality/aging
• homozygous mice show an increased susceptibility to dextran sodium sulfate-induced colitis with 50% mortality by the end of 7 days
|
• homozygous mice show reduced viability with 50% mortality at 48 weeks and 69% mortality by 104 weeks
|
• there is 20% mortality of homozygotes by time of weaning
|
growth/size/body
• homozygous mice show growth delay; at 3 weeks, male mutants weigh 12.1 grams compared to 15.1 grams for heterozygotes and 5.9 grams for wild-type
|
digestive/alimentary system
• after 5 days of DSS treatment, homozygous mice show areas of complete erosion of crypt architecture, grossly visible hemorrhage and extensive submucosal edema, while control mice have only localized areas of lymphocytic infiltration, and heterozygotes show displaced normal crypt architecture and edema with more extensive infiltration than controls
|
immune system
• after 5 days of DSS treatment, homozygous mice show areas of complete erosion of crypt architecture, grossly visible hemorrhage and extensive submucosal edema, while control mice have only localized areas of lymphocytic infiltration, and heterozygotes show displaced normal crypt architecture and edema with more extensive infiltration than controls
|
homeostasis/metabolism
• homozygous mice show an increased susceptibility to dextran sodium sulfate-induced colitis with 50% mortality by the end of 7 days
|